Collegium Pharmaceutical Inc (COLL)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 169,895 | 166,961 | -104,573 | -46,699 | -5,086 |
| Total assets | US$ in thousands | 1,663,590 | 1,143,310 | 1,174,130 | 692,077 | 643,841 |
| Operating ROA | 10.21% | 14.60% | -8.91% | -6.75% | -0.79% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $169,895K ÷ $1,663,590K
= 10.21%
Collegium Pharmaceutical Inc's operating return on assets (operating ROA) experienced fluctuations over the period from December 31, 2020, to December 31, 2024. The operating ROA was negative in the initial years, indicating inefficiency in generating operating earnings from its assets. However, the company showed significant improvement in later years, with the operating ROA turning positive and reaching 14.60% by December 31, 2023. This suggests that Collegium Pharmaceutical Inc became more effective in utilizing its assets to generate operating profits. The trend continued positively as of December 31, 2024, where the operating ROA stood at 10.21%. Overall, the increasing trend in operating ROA indicates improved operational efficiency and profitability for Collegium Pharmaceutical Inc over the analyzed period.
Peer comparison
Dec 31, 2024